DGAP-News: Fresenius Medical Care AG&Co. KGaA: Announces Management Board Change
(firmenpresse) - DGAP-News: Fresenius Medical Care AG&Co. KGaA / Key word(s): Change
of Personnel
Fresenius Medical Care AG&Co. KGaA: Announces Management Board
Change
17.09.2012 / 08:17
---------------------------------------------------------------------
September 17, 2012
Fresenius Medical Care Announces Management Board Change
Bad Homburg, Germany - Fresenius Medical Care AG&Co. KGaA ('the company'
or 'Fresenius Medical Care'), the world's largest provider of dialysis
products and services, today announced a change in its Management Board.
The Supervisory Board of Fresenius Medical Care Management AG has appointed
Ronald (Ron) Kuerbitz as a Management Board member, effective January 1,
2013. Mr. Kuerbitz will succeed Rice Powell as CEO of Fresenius Medical
Care North America. This appointment is part of the company's succession
plan to ensure a smooth transition of leadership in North America. Mr.
Powell will assume the role of CEO, Fresenius Medical Care AG&Co. KGaA,
and Chairman of the Management Board, effective January 1, 2013 as
announced in March of 2012.
Ron Kuerbitz currently serves as Executive Vice President responsible for
Market Development and Administration for Fresenius Medical Care North
America. He joined Fresenius Medical Care in 1997 to lead its corporate
development function and was later named as Fresenius Medical Care North
America's General Counsel and Chief Administrative Officer. Mr. Kuerbitz
has 20 years of experience in the health care field, having held positions
in law, compliance, business development, government affairs and
operations. Since 2011 Mr. Kuerbitz has served as Chairman of Kidney Care
Partners in Washington D.C., a coalition of patient advocates, dialysis
professionals, care providers and device and pharmaceutical manufacturers
working together to improve the quality of care for individuals with
chronic kidney disease. Mr. Kuerbitz is a graduate of Albion College and
received his juris doctor degree from the Yale Law School.
'We are pleased to facilitate an orderly transition process with the
appointment of Ron Kuerbitz as CEO for Fresenius Medical Care North
America,' said Ben Lipps, Chief Executive Officer of Fresenius Medical Care
and Chairman of the Management Board. 'Ron's successful record and his
extensive management experience within Fresenius Medical Care and the
health care field qualify him superbly for the position. The fact that this
appointment has been filled internally reflects the strength and depth of
our management team and will ensure a smooth transition going forward'.
Ulf Mark Schneider, Chairman of the Supervisory Board of Fresenius Medical
Care Management AG, said: 'Ron has made outstanding contributions to the
success of Fresenius Medical Care over the years. With his superb
understanding of the strategic and regulatory opportunities and challenges
ahead of us, Ron's leadership will ensure the continued success of the
company. We are looking forward to working with him in his new role'.
Fresenius Medical Care is the world's largest integrated provider of
products and services for individuals undergoing dialysis because of
chronic kidney failure, a condition that affects more
than 2.1 million individuals worldwide. Through its network of 3,123
dialysis clinics in North America, Europe, Latin America, Asia-Pacific and
Africa, Fresenius Medical Care provides dialysis treatment to 256,456
patients around the globe. Fresenius Medical Care is also the world's
leading provider of dialysis products such as hemodialysis machines,
dialyzers and related disposable products.
For more information about Fresenius Medical Care, visit the Company's
website at www.fmc-ag.com.
Disclaimer
This release contains forward-looking statements that are subject to
various risks and uncertainties. Actual results could differ materially
from those described in these forward-looking statements due to certain
factors, including changes in business, economic and competitive
conditions, regulatory reforms, foreign exchange rate fluctuations,
uncertainties in litigation or investigative proceedings, and the
availability of financing. These and other risks and uncertainties are
detailed in Fresenius Medical Care AG&Co. KGaA's reports filed with the
U.S. Securities and Exchange Commission. Fresenius Medical Care AG&Co.
KGaA does not undertake any responsibility to update the forward-looking
statements in this release.
End of Corporate News
---------------------------------------------------------------------
17.09.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Fresenius Medical Care AG&Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Phone: +49 (0) 6172- 609 2525
Fax: +49 (0) 6172- 609 2301
E-mail: ir(at)fmc-ag.com
Internet: www.fmc-ag.de
ISIN: DE0005785802, DE0005785836,
WKN: 578580, 578583
Indices: DAX
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover,
München, Stuttgart; Terminbörse EUREX; NYSE
End of News DGAP News-Service
---------------------------------------------------------------------
185342 17.09.2012
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: EquityStory
" alt="CaNickel announce Share Consolidation
Datum: 17.09.2012 - 08:17 Uhr
Sprache: Deutsch
News-ID 183689
Anzahl Zeichen: 0
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 270 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Fresenius Medical Care AG&Co. KGaA: Announces Management Board Change"
steht unter der journalistisch-redaktionellen Verantwortung von
Fresenius Medical Care AG&Co. KGaA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
